Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.

Author: AlbertiD, AntigaL, BedognaV, CasagrandeP, Dal SantoF, MaschioG, PerobelliL, ValvoE, ZamboniM

Paper Details 
Original Abstract of the Article :
Seventeen essential hypertensive patients with normal renal function were treated with a new non-sulphydryl orally active angiotensin converting enzyme (ACE) inhibitor, benazepril, 10 mg given once or twice daily, according to diastolic blood pressure levels, for 6 weeks. In all patients, changes in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00004872-199011000-00003

データ提供:米国国立医学図書館(NLM)

Systemic and Renal Effects of Benazepril: A Journey Through the Desert of Hypertension

Hypertension, a silent threat that can feel like a relentless sandstorm on the cardiovascular system, requires effective management. This study, like a team of researchers exploring the effects of a new drug, investigates the systemic and renal effects of benazepril, a non-sulphydryl angiotensin converting enzyme (ACE) inhibitor, in patients with essential hypertension. The researchers, like skilled physicians, carefully monitor the effects of benazepril on blood pressure, systemic and renal hemodynamics, and various hormonal markers, seeking to understand its impact on cardiovascular and renal function.

Navigating the Desert of Hypertension: A New Path to Blood Pressure Control

The study demonstrates that benazepril, like a skilled desert guide, effectively controls blood pressure while maintaining normal renal function. The researchers observed a significant decrease in peripheral vascular resistance, a key factor in regulating blood pressure, suggesting that benazepril promotes vasodilation. This is like finding a path through the desert that leads to a more open and less constricted route, promoting a smoother flow of blood throughout the body.

A New Oasis in Hypertension Treatment: Improving Cardiovascular Health

This research offers valuable insights into the potential benefits of benazepril in managing hypertension. It highlights the ability of this drug to control blood pressure while preserving renal function, offering a potential solution for patients navigating the complex terrain of cardiovascular health.

Dr.Camel's Conclusion

This study offers a promising oasis in the desert of hypertension treatment. Benazepril's effectiveness in controlling blood pressure while maintaining renal function provides a valuable option for patients seeking a safe and effective approach to managing this prevalent health condition.
Date :
  1. Date Completed 1991-03-29
  2. Date Revised 2019-08-20
Further Info :

Pubmed ID

1963190

DOI: Digital Object Identifier

10.1097/00004872-199011000-00003

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.